scholarly journals Hypercalcemia is a frequent side effect of 13‐ cis ‐retinoic acid treatment in patients with high‐risk neuroblastoma

2021 ◽  
Author(s):  
Marc Hoemberg ◽  
Ruth Schwenzfeur ◽  
Frank Berthold ◽  
Thorsten Simon ◽  
Barbara Hero
Keyword(s):  
Retinoic Acid ◽  
High Risk ◽  
Side Effect ◽  
Acid Treatment ◽  
Retinoic Acid Treatment

scholarly journals Sequential Valproic Acid/All-trans Retinoic Acid Treatment Reprograms Differentiation in Refractory and High-Risk Acute Myeloid Leukemia

2006 ◽  
Vol 66 (17) ◽  
pp. 8903-8911 ◽  
Author(s):  
Giuseppe Cimino ◽  
Francesco Lo-Coco ◽  
Susanna Fenu ◽  
Lorena Travaglini ◽  
Erica Finolezzi ◽  
...  
Keyword(s):  
Valproic Acid ◽  
Acute Myeloid Leukemia ◽  
Retinoic Acid ◽  
High Risk ◽  
Myeloid Leukemia ◽  
Acid Treatment ◽  
Retinoic Acid Treatment ◽  
Trans Retinoic Acid ◽  
All Trans Retinoic Acid ◽  
Acute Myeloid

scholarly journals All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo

Oncogene ◽  
2005 ◽  
Vol 24 (33) ◽  
pp. 5246-5251 ◽  
Author(s):  
Birgit Zirn ◽  
Birgit Samans ◽  
Christian Spangenberg ◽  
Norbert Graf ◽  
Martin Eilers ◽  
...  
Keyword(s):  
Retinoic Acid ◽  
High Risk ◽  
Tumor Cells ◽  
Acid Treatment ◽  
Wilms Tumor ◽  
Retinoic Acid Treatment ◽  
Trans Retinoic Acid ◽  
Expression Of Genes ◽  
All Trans Retinoic Acid

scholarly journals Expression of Sec61alpha in F9 and P19 teratocarcinoma cells after retinoic acid treatment

2003 ◽  
Vol 63 (2) ◽  
pp. 245-252 ◽  
Author(s):  
L. R. Ferreira ◽  
C. E. E. Velano ◽  
E. C. Braga ◽  
C. C. Paula ◽  
H. Martélli-Junior ◽  
...  
Keyword(s):  
Stem Cells ◽  
Retinoic Acid ◽  
Acid Treatment ◽  
Secretory Proteins ◽  
P19 Cells ◽  
Retinoic Acid Treatment ◽  
Teratocarcinoma Cell ◽  
F9 Cells ◽  
Teratocarcinoma Cells ◽  
Differentiation Stage

Nascent procollagen peptides and other secretory proteins are transported across the endoplasmic reticulum (RE) membrane through a protein-conducting channel called the translocon. Sec61alpha, a multispanning membrane translocon protein, has been implicated as essential for translocation of polypeptides chains into the cisterns of the ER. However, it is not known whether Sec61alpha is ubiquitously expressed in collagen producing teratocarcinoma cells. Furthermore, the production, expression, and utilization of Sec61alpha may depend on the cell differentiation stage. Stem cells from many cultured teratocarcinoma cell lines such as F9 and P19 cells are capable of differentiation in response to low retinoic acid concentrations. This differentiation of the tumorigenic stem cells results in tumorigenicity loss. For this study, mouse F9 and P19 teratocarcinoma cells were grown in culture medium treated with or without retinoic acid. Expression of Sec61alpha was determined by reverse trancriptase polimerase chain reaction (RT-PCR). In untreated conditions, F9 cells expressed undetected Sec61alpha amounts. It was also demonstrated that Sec61alpha expression is stimulated in F9 cells after retinoic acid treatment for 72 hours. No changes were found in Sec61alpha expression in P19 cells after retinoic acid treatment. These data indicate that the expression of Sec61alpha is enhanced with retinoic acid induced differentiation of F9 teratocarcinoma cells.

Sign in / Sign up

Export Citation Format

Share Document